Professor Sam Janes, Clinical Advisor for Lung Cancer

Professor of Respiratory Medicine at University College London (UCL) and Director of Respiratory Research at UCL

More men and more women die of lung cancer than any other cancer. Survival rates are currently low because it is detected late. The key for the future is to improve testing to allow early diagnosis of lung cancer and other cancers when they can be cured.

Sam Janes is Professor of Respiratory Medicine at University College London (UCL) and Director of Respiratory Research at UCL.

He has strong research interest in improving diagnostic techniques for lung cancer. Professor Janes qualified in 1992. He leads a group interested in the pathogenesis of lung disease including cancer formation and its treatment with new biological and cellular therapies within UCL Respiratory Research Department. He has a particular interest in early diagnosis of lung cancer. In 2012, he formed the ‘Lungs for Living Research Centre’ supported by the UCLH Charitable Foundation focusing on researching early lung cancer and the role of stem cells in its formation and treatments. His important work has been recognised by a number of international awards for his research team and the personal award of European Thoracic Oncology Investigator of the Year in 2010.

Professor Janes has published around 150 papers on lung cancer in journals such as ‘Nature’, and ’Nature Medicine’ and he sits on scientific committees assessing research proposals. Professor Janes also spends time helping  CRUK, Roy Castle Lung Cancer Foundation and MacMillan with academic assessments, and public facing brochures. He is the lead of four academic randomised clinical trials and most notably recently launched the SUMMIT study, a 25,000 participant London based study examining CT and blood screening for lung and other cancers.